Cargando…
The Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China
Autores principales: | Tse, Gary, Shao, Qun, Liu, Jiwei, Zhang, Yuhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982202/ https://www.ncbi.nlm.nih.gov/pubmed/36875905 http://dx.doi.org/10.1016/j.jaccao.2023.01.003 |
Ejemplares similares
-
ESC Cardio-Oncology Guidelines: A Triumph—But Are We Overscreening?
por: Witteles, Ronald M., et al.
Publicado: (2022) -
The ESC Cardio-Oncology Guidelines: A Roadmap for Clinical Practice and Generating Needed Evidence
por: Sparano, Joseph A., et al.
Publicado: (2022) -
The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022) -
Clinical Practice Guidelines in Cardio-Oncology: A Sea of Opportunity
por: Sase, Kazuhiro, et al.
Publicado: (2022) -
Cardio-Oncology Guidelines and Strength of the Evidence
por: Zheng, Haoyi, et al.
Publicado: (2023)